Treatment of COVID-19: a review of current and prospective pharmacotherapies.
Br J Hosp Med (Lond)
; 82(3): 1-9, 2021 Mar 02.
Article
em En
| MEDLINE
| ID: mdl-33792391
ABSTRACT
The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) continues to spread and have grave health and socioeconomic consequences worldwide. Researchers have raced to understand the pathophysiological mechanisms underpinning the disease caused by SARS-CoV-2 so that effective therapeutic targets can be discovered. This review summarises the key pharmacotherapies that are being investigated for treatment of COVID-19, including antiviral, immunomodulator and anticoagulation strategies.
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Antivirais
/
Inibidores da Agregação Plaquetária
/
Tratamento Farmacológico da COVID-19
/
Glucocorticoides
/
Fatores Imunológicos
/
Anticoagulantes
Limite:
Humans
Idioma:
En
Ano de publicação:
2021
Tipo de documento:
Article